Cited by 253Epilepsy research and treatmentNeuroinflammation and Neurodegeneration MechanismsTraumatic Brain Injury and Neurovascular Disturbances

Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage

Librizzi, Laura, Noè, Francesco, Vezzani, Annamaria, de Curtis, Marco, Ravizza, Teresa·2012·Annals of Neurology

Abstract

OBJECTIVE: Epilepsy is a common neurological disorder characterized by recurrent seizures often unresponsive to pharmacological treatment. Brain inflammation is considered a crucial etiopathogenetic mechanism of epilepsy that could be targeted to control seizures. Specific inflammatory mediators overexpressed in human epileptogenic foci are known to promote seizures in animal models. We investigated whether seizures induce brain inflammation independently on extracerebral factors. We also investigated whether brain-borne inflammation is required and sufficient to maintain seizure activity and whether it causes blood-brain barrier (BBB) impairment. We addressed these questions by studying the relation between seizures, inflammation, and BBB permeability in a brain preparation isolated from extracerebral compartments. METHODS: Epileptiform activity was induced by arterial perfusion of bicuculline in the in vitro isolated guinea pig brain. Seizure-induced brain inflammation was evaluated by quantitative immunohistochemical analysis of interleukin (IL)-1β in parenchymal cells. BBB damage was assessed by extravasation of intravascular fluorescein isothiocyanate-albumin. The effects of arterially perfused anakinra, a human recombinant IL-1β receptor antagonist, were investigated on epileptiform discharges, brain inflammation, and BBB damage. RESULTS: Seizure induction in the absence of extracerebral factors promoted the release of IL-1β from brain resident cells and enhanced its biosynthesis in astrocytes. Anakinra rapidly terminated seizures, prevented their recurrence, and resolved seizure-associated BBB breakdown. INTERPRETATION: Seizures initiate brain inflammation in glia and promote BBB damage that is independent of either leukocytes or blood-borne inflammatory molecules. Brain inflammation contributes to the duration and recurrence of seizures. This study supports the use of specific anti-inflammatory drugs in clinical conditions that present with intractable recurrent seizures.

Integrity signals

Registry

Crossref · 10.1002/ana.23567

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-1R1 activation on ECs increases BBB permeability through downregulation of tight junction proteins, mainly ZO-1, and upregulation of NO and MMPs.

    “IL-1R1 activation on ECs increases BBB permeability through downregulation of tight junction proteins, mainly ZO-1, and upregulation of NO and MMPs (Ravizza et al., 2008a,b; Morin-Brureau et al., 2011; Librizzi et al., 2012).”

    From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Librizzi et al., 2012

  • Microglial and astrocytic IL-1β act directly on the endothelium, altering BBB permeability and contributing to epileptogenesis.

    “Microglial and astrocytic IL-1β act directly on the endothelium, altering BBB permeability and contributing to epileptogenesis.”

    From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Librizzi et al., 2012

  • The interaction between microglia and ECs is important in epilepsy.

    “These studies further suggest the importance of the interaction between microglia and ECs in epilepsy.”

    From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Librizzi et al., 2012

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Librizzi, L., Noè, F., Vezzani, A., de Curtis, M., & Ravizza, T.
Affiliations
  • Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
  • Mario Negri Institute for Pharmacological Research (IT)
Corresponding author
Ravizza, Teresa
Venue
Annals of Neurology
Publisher
Wiley
Published
2012-07
Volume
72
Issue
1
Pages
82-90
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2104387508
Cited by
253
References
50
Citations by year
2026: 6 · 2025: 13 · 2024: 11 · 2023: 16 · 2022: 13 · 2021: 22 · 2020: 13 · 2019: 26 · 2018: 21 · 2017: 13 · 2016: 24 · 2015: 23 · 2014: 27 · 2013: 20 · 2012: 5
FWCI
17.10
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
seizure recurrence, blood-brain barrier disruption, IL-1β, anakinra, interleukin-1 receptor antagonist, astrocytes, epileptiform activity, bicuculline, anti-inflammatory therapy, drug-resistant epilepsy
MeSH terms
Animals, Astrocytes, Bicuculline, Blood-Brain Barrier, Brain, Encephalitis, Epilepsy, Guinea Pigs, Recurrence, Seizures, Interleukin-1beta, Interleukin 1 Receptor Antagonist Protein, GABA-A Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review